Generic drug licensing web site from Pharmalicensing/ICE Pharma
UTEK Corp, a Florida, USA-based innovation services company, has announced the launch of a new web site, www.genericlicensing.com. The site represents a joint venture between UTEK's Pharmalicensing division and ICE Pharma Group, a UK development, manufacturing and service company active in the global generic and speciality pharmaceutical industries.
Genericlicensing.com has been developed to become an essential business tool for licensing and contract developments for the generic pharmaceutical sector. The site provides a comprehensive database of approved, available and in-development generic products.
There are a number of key features and tool-sets that will now make the task of obtaining new generic products easier for paid subscribers, the companies point out. These include:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze